Home / Healthcare / Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Published: Oct 2017 | No Of Pages: 466 | Published By: GlobalData

Summary

GlobalData's Medical Devices sector report, “Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the productÂ’s current stage of development, territory and estimated launch date

1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 18

2 Introduction 19
2.1 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests Overview 19

3 Products under Development 20
3.1 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Stage of Development 20
3.2 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Territory 21
3.3 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Regulatory Path 22
3.4 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Estimated Approval Date 23
3.5 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Ongoing Clinical Trials 24

4 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products under Development by Companies 25
4.1 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests Companies - Pipeline Products by Stage of Development 25
4.2 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Stage of Development 29

5 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests Companies and Product Overview 34
5.1 Abreos Biosciences Inc Company Overview 34
5.2 Acetaminophen Toxicity Diagnostics, LLC Company Overview 35
5.3 Advanced Liquid Logic Inc Company Overview 36
5.4 Affinimark Technologies, Inc. Company Overview 38
5.5 Alere Inc Company Overview 39
5.6 Alfa Wassermann Inc Company Overview 40
5.7 Am Biotechnologies, LLC Company Overview 42
5.8 Analyticon Biotechnologies AG Company Overview 46
5.9 AnaZyme, LLC Company Overview 49
5.10 Applied Research using OMIC Sciences SL Company Overview 51
5.11 Arquer Diagnostics Ltd Company Overview 52
5.12 Atonomics A/S Company Overview 54
5.13 Augurix SA Company Overview 55
5.14 Axela Inc Company Overview 58
5.15 Baebies, Inc. Company Overview 59
5.16 Banyan Biomarkers Inc Company Overview 60
5.17 Beacon Biomedical Inc Company Overview 61
5.18 Bio-Alternative Medical Devices Ltd Company Overview 62
5.19 BioAssay Works, LLC Company Overview 63
5.20 Biocross SL Company Overview 64
5.21 Bioftalmik Applied Research Company Overview 65
5.22 Biohit Oyj Company Overview 66
5.23 Biomedical Diagnostics Institute Company Overview 67
5.24 BioMedomics Inc Company Overview 69
5.25 Biopico Systems Inc. Company Overview 73
5.26 Bio-Rad Laboratories Inc Company Overview 74
5.27 Biosensia Ltd Company Overview 75
5.28 Carclo Diagnostic Solutions Ltd Company Overview 76
5.29 CardioGenics Inc Company Overview 78
5.30 Cellex Inc. Company Overview 81
5.31 Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Company Overview 82
5.32 Claremont BioSolutions Company Overview 83
5.33 Columbia University Company Overview 84
5.34 CTK Biotech, Inc. Company Overview 86
5.35 Dartmouth College Company Overview 87
5.36 DiabetOmics Inc Company Overview 90
5.37 DiagnosTear Ltd. Company Overview 91
5.38 DiaSys Diagnostic Systems GmbH Company Overview 94
5.39 DxDiscovery, Inc. Company Overview 97
5.40 Dynasil Corporation of America Company Overview 98
5.41 ECI Biotech Inc. Company Overview 99
5.42 Edan Instruments Inc Company Overview 101
5.43 Enigma Diagnostics Ltd (Inactive) Company Overview 102
5.44 FK-Biotecnologia SA Company Overview 104
5.45 Foundation for Innovative New Diagnostics Company Overview 107
5.46 Gendiag Company Overview 108
5.47 GeneEx, Inc (Inactive) Company Overview 109
5.48 Glide Pharmaceutical Technologies Ltd Company Overview 110
5.49 Instrumentation Laboratory Company Company Overview 111
5.50 Integrated Diagnostics Inc Company Overview 112
5.51 Intelligent Optical Systems, Inc. Company Overview 113
5.52 IntraMed Diagnostics, LLC Company Overview 114
5.53 IR2Dx Inc. Company Overview 117
5.54 Iron Horse Diagnostics, Inc. Company Overview 118
5.55 Kenyatta University Company Overview 119
5.56 LeukoDx Ltd Company Overview 120
5.57 Magnisense SAS Company Overview 122
5.58 Makerere University Company Overview 123
5.59 Massachusetts Institute of Technology Company Overview 124
5.60 Medical University of South Carolina Company Overview 126
5.61 Micronics Inc Company Overview 129
5.62 Montana State University Company Overview 130
5.63 Myotherapeutics LLC (Inactive) Company Overview 131
5.64 NanoSpeed Diagnostics Inc Company Overview 132
5.65 NicOx SA Company Overview 135
5.66 North-West University Company Overview 137
5.67 Northwestern University Company Overview 138
5.68 Novartis AG Company Overview 139
5.69 Oasis Diagnostics Corp Company Overview 143
5.70 Ohmx Corp Company Overview 145
5.71 OJ-Bio Ltd Company Overview 150
5.72 OPKO Health Inc Company Overview 151
5.73 Oxford Immunotec Ltd Company Overview 153
5.74 P2D Bioscience Company Overview 154
5.75 Philips Healthcare Company Overview 156
5.76 Pop Test LLC Company Overview 157
5.77 PortaScience Inc Company Overview 160
5.78 QuantuMDx Group Ltd Company Overview 161
5.79 Quidel Corp Company Overview 163
5.80 Rice University Company Overview 166
5.81 SaltCheck Inc (Inactive) Company Overview 167
5.82 Sedia Biosciences Corp Company Overview 168
5.83 SenGenix Inc Company Overview 169
5.84 SoftRay Inc. Company Overview 171
5.85 STIgma Free Diagnostics, LLC Company Overview 172
5.86 SuperNova Diagnostics, Inc. Company Overview 173
5.87 Systagenix Wound Management Ltd Company Overview 174
5.88 The Forsyth Institute Company Overview 176
5.89 The University of New South Wales Company Overview 177
5.90 The University of South Australia Company Overview 178
5.91 Thermo Fisher Scientific Inc Company Overview 179
5.92 Trinity Biotech Plc Company Overview 181
5.93 Trivitron Healthcare Pvt Ltd Company Overview 183
5.94 Universal Biosensors Inc Company Overview 184
5.95 University College Cork Company Overview 186
5.96 University of Alberta Company Overview 187
5.97 University of Antwerp Company Overview 188
5.98 University of Edinburgh Company Overview 191
5.99 University of Oxford Company Overview 192
5.100 University of South Florida Company Overview 193
5.101 Vasculogic, LLC. Company Overview 194
5.102 Vivonics, Inc. Company Overview 195
5.103 VolitionRX Ltd Company Overview 196
5.104 Wave 80 Biosciences Inc Company Overview 197
5.105 Wellstat Diagnostics LLC Company Overview 198
5.106 WOUNDCHEK Laboratories Company Overview 199
5.107 Xcellence in Bio Innovations & Technologies Pvt Ltd Company Overview 201
5.108 Yale University Company Overview 202

6 Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests- Recent Developments 203
6.1 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma 203
6.2 Sep 11, 2017: EKF Diagnostics Holdings: Half Yearly Report 203
6.3 Sep 08, 2017: Nicox first half 2017 business and financial update 203
6.4 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 204
6.5 Sep 07, 2017: Akers Biosciences Hires Medical Device Specialist to Lead US Sales and Distribution 205
6.6 Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO's BioReference Laboratories 206
6.7 Sep 04, 2017: DiagnosTear - Recruitment of the first participant for clinical trial using the TeaRx technology 206
6.8 Sep 04, 2017: Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018. 207
6.9 Sep 01, 2017: Management changes resulting from sale of DIAsource 208
6.10 Sep 01, 2017: Anteo Diagnostics: 30 June 2017 Preliminary Financial Statements 208
6.11 Aug 30, 2017: bioMerieux - First-Half 2017 Results 209
6.12 Aug 24, 2017: Novartis appoints Bertrand Bodson as Chief Digital Officer 212
6.13 Aug 24, 2017: Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN 213
6.14 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers 213
6.15 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson 214
6.16 Aug 17, 2017: Biohit Group Half Year Financial Report 2017 214
6.17 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories 219
6.18 Aug 17, 2017: Span Diagnostics announces resignation of CFO 219
6.19 Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results 219
6.20 Aug 15, 2017: Akers Biosciences: Financial Results for the Six Months Ended June 30, 2017 220
6.21 Aug 15, 2017: Akers Biosciences Announces Q2 2017 Earnings 222
6.22 Aug 14, 2017: Carolina Vision Care Announces New Dry Eye Test with Heightened Accuracy 227
6.23 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update 227
6.24 Aug 08, 2017: Akers Biosciences Announces Board Changes 229
6.25 Aug 07, 2017: Rick Legleiter Appointed Chief Executive Officer, Chairman Succession and Board Renewal Process 230
6.26 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter 231
6.27 Aug 03, 2017: Ora Appoints Experienced Clinical Operations Leader Amid Strong Demand for Global Ophthalmology CRO Services 233
6.28 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 234
6.29 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 234
6.30 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 235
6.31 Aug 03, 2017: Akers Biosciences Announces Second Quarter Trading Update 236
6.32 Aug 01, 2017: llumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017 236
6.33 Aug 01, 2017: Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017 237
6.34 Jul 31, 2017: Sysmex America Completes Expansion of Reagents Manufacturing Facility, Opens Doors to Latin American Sales Office in Doral, Florida 238
6.35 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions 238
6.36 Jul 27, 2017: Abaxis Reports Financial Performance for the First Quarter of Fiscal 2018 and Declares Quarterly Cash Dividend 245
6.37 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 246
6.38 Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results 248
6.39 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 250
6.40 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 252
6.41 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017 254
6.42 Jul 18, 2017: Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products 256
6.43 Jul 18, 2017: Hans E. Bishop to Join Agilent's Board of Directors 261
6.44 Jul 13, 2017: Parallax Health Sciences Appoints Paul Arena as Chief Executive Officer 262
6.45 Jul 06, 2017: Kurt H. Kruger joins Qualigen's Board of Directors 264
6.46 Jul 06, 2017: Richard David, MD, FACS joins Qualigen's Board of Directors 265
6.47 Jul 03, 2017: Premaitha Health Litigation Update 265

7 Appendix 461
7.1 Methodology 461
7.2 About GlobalData 464
7.3 Contact Us 464
7.4 Disclaimer 464

Table 1: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Stage of Development 22
Table 2: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Territory 23
Table 3: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Regulatory Path 24
Table 4: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
Table 5: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Ongoing Clinical Trials 26
Table 6: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests Companies - Pipeline Products by Stage of Development 27
Table 7: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Stage of Development 31
Table 8: Abreos Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 9: Veritope Lateral Flow Immunoassay - Therapeutic Drug Dosing - Product Status 36
Table 10: Veritope Lateral Flow Immunoassay - Therapeutic Drug Dosing - Product Description 36
Table 11: Acetaminophen Toxicity Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 37
Table 12: AcetaSTAT(r) - Product Status 37
Table 13: AcetaSTAT(r) - Product Description 37
Table 14: Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 15: Carboxyhemoglobin Levels Multiplex Assay - Product Status 38
Table 16: Carboxyhemoglobin Levels Multiplex Assay - Product Description 38
Table 17: Unbound Bilirubin Multiplex Assay - Product Status 39
Table 18: Unbound Bilirubin Multiplex Assay - Product Description 39
Table 19: Affinimark Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 20: Cerebrostrip Diagnostic Test - Product Status 40
Table 21: Cerebrostrip Diagnostic Test - Product Description 40
Table 22: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 23: Afinion Lipid/Cholesterol Test Panel - Product Status 41
Table 24: Afinion Lipid/Cholesterol Test Panel - Product Description 41
Table 25: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 26: ACE Alera Clinical Chemistry System - Direct A1c Assay - Product Status 42
Table 27: ACE Alera Clinical Chemistry System - Direct A1c Assay - Product Description 42
Table 28: ACE Alera Clinical Chemistry System - Enzymatic Creatinine Assay - Product Status 43
Table 29: ACE Alera Clinical Chemistry System - Enzymatic Creatinine Assay - Product Description 43
Table 30: ACE Axcel Clinical Chemistry System - Enzyme Creatinine Assay - Product Status 43
Table 31: ACE Axcel Clinical Chemistry System - Enzyme Creatinine Assay - Product Description 43
Table 32: Am Biotechnologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 44
Table 33: Thioaptamer Diagnostic System - CTx Biomarker - Product Status 44
Table 34: Thioaptamer Diagnostic System - CTx Biomarker - Product Description 44
Table 35: Thioaptamer Diagnostic System - OC Biomarker - Product Status 45
Table 36: Thioaptamer Diagnostic System - OC Biomarker - Product Description 45
Table 37: Thioaptamer Diagnostic System - sALP Biomarker - Product Status 45
Table 38: Thioaptamer Diagnostic System - sALP Biomarker - Product Description 46
Table 39: Thioaptamers Diagnostic System - Gpx Biomarker - Product Status 46
Table 40: Thioaptamers Diagnostic System - Gpx Biomarker - Product Description 46
Table 41: Thioaptamers Diagnostic System - NTx Biomarker - Product Status 47
Table 42: Thioaptamers Diagnostic System - NTx Biomarker - Product Description 47
Table 43: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 48
Table 44: CRPslide Latex Slide Test - Product Status 48
Table 45: CRPslide Latex Slide Test - Product Description 49
Table 46: RFslide Latex Slide Test - Product Status 49
Table 47: RFslide Latex Slide Test - Product Description 49
Table 48: SLEslide Latex Slide Test - Product Status 50
Table 49: SLEslide Latex Slide Test - Product Description 50
Table 50: AnaZyme, LLC Pipeline Products & Ongoing Clinical Trials Overview 51
Table 51: Blood Based Assay - Absence Of Specific Compounds - Product Status 51
Table 52: Blood Based Assay - Absence Of Specific Compounds - Product Description 51
Table 53: Blood Based Assay - Specific Enzymes - Product Status 52
Table 54: Blood Based Assay - Specific Enzymes - Product Description 52
Table 55: Applied Research using OMIC Sciences SL Pipeline Products & Ongoing Clinical Trials Overview 53
Table 56: SNP-test - Product Status 53
Table 57: SNP-test - Product Description 53
Table 58: Arquer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
Table 59: UroSens Mcm5 POC Diagnostic Test - Bladder Cancer - Product Status 54
Table 60: UroSens Mcm5 POC Diagnostic Test - Bladder Cancer - Product Description 54
Table 61: UroSens Mcm5 POC Diagnostic Test - Prostate Cancer - Product Status 55
Table 62: UroSens Mcm5 POC Diagnostic Test - Prostate Cancer - Product Description 55
Table 63: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 56
Table 64: Trace Lipid Test Panel - Home Use - Product Status 56
Table 65: Trace Lipid Test Panel - Home Use - Product Description 56
Table 66: Augurix SA Pipeline Products & Ongoing Clinical Trials Overview 57
Table 67: AUG-POC2 - Product Status 57
Table 68: AUG-POC2 - Product Description 57
Table 69: AUG-POC3 - Product Status 58
Table 70: AUG-POC3 - Product Description 58
Table 71: AUG-POC4 - Product Status 58
Table 72: AUG-POC4 - Product Description 59
Table 73: AUG-POC5 - Product Status 59
Table 74: AUG-POC5 - Product Description 59
Table 75: Axela Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 76: Point-Of-Care Diagnostic Test - TBI - Product Status 60
Table 77: Point-Of-Care Diagnostic Test - TBI - Product Description 60
Table 78: Baebies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 79: Point-Of-Care Test - Hyperbilirubinemia - Product Status 61
Table 80: Point-Of-Care Test - Hyperbilirubinemia - Product Description 61
Table 81: Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Table 82: Banyan UCH-L1/GFAP Detection Assay - Product Status 62
Table 83: Banyan UCH-L1/GFAP Detection Assay - Product Description 62
Table 84: Beacon Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 85: ColoRT - Product Status 63
Table 86: ColoRT - Product Description 63
Table 87: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 64
Table 88: Digital Strip Reader - Cholesterol - Product Status 64
Table 89: Digital Strip Reader - Cholesterol - Product Description 64
Table 90: BioAssay Works, LLC Pipeline Products & Ongoing Clinical Trials Overview 65
Table 91: Diagnostic Test - Smallpox - Product Status 65
Table 92: Diagnostic Test - Smallpox - Product Description 65
Table 93: Biocross SL Pipeline Products & Ongoing Clinical Trials Overview 66
Table 94: Degenerative Dementia Test - Product Status 66
Table 95: Degenerative Dementia Test - Product Description 66
Table 96: Bioftalmik Applied Research Pipeline Products & Ongoing Clinical Trials Overview 67
Table 97: Diagnostic Test - Pediatric Ocular Allergy - Product Status 67
Table 98: Diagnostic Test - Pediatric Ocular Allergy - Product Description 67
Table 99: Biohit Oyj Pipeline Products & Ongoing Clinical Trials Overview 68
Table 100: Lactose Intolerance Quick Test - Product Status 68
Table 101: Lactose Intolerance Quick Test - Product Description 68
Table 102: Biomedical Diagnostics Institute Pipeline Products & Ongoing Clinical Trials Overview 69
Table 103: Colorectal Cancer Multi-marker Diagnostic Assay - Product Status 69
Table 104: Colorectal Cancer Multi-marker Diagnostic Assay - Product Description 69
Table 105: Nucleic-acid Based Diagnostic Test - Product Status 70
Table 106: Nucleic-acid Based Diagnostic Test - Product Description 70
Table 107: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 71
Table 108: Rapid Drug Overdose Test - Methamphetamine - Product Status 71
Table 109: Rapid Drug Overdose Test - Methamphetamine - Product Description 71
Table 110: Rapid Drug Overdose Test - Morphine - Product Status 72
Table 111: Rapid Drug Overdose Test - Morphine - Product Description 72
Table 112: Rapid Drug Overdose Test - PCP - Product Status 72
Table 113: Rapid Drug Overdose Test - PCP - Product Description 73
Table 114: Rapid Drug Overdose Test - THC - Product Status 73
Table 115: Rapid Drug Overdose Test - THC - Product Description 73
Table 116: Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test - Product Status 74
Table 117: Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test - Product Description 74
Table 118: Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
Table 119: Biomarker Based Test - Systemic Lupus Erythematosus - Product Status 75
Table 120: Biomarker Based Test - Systemic Lupus Erythematosus - Product Description 75
Table 121: Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 76
Table 122: Droplet Digital PCR - MRSA Infection - Product Status 76
Table 123: Droplet Digital PCR - MRSA Infection - Product Description 76
Table 124: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
Table 125: RapiPlex Platform - Kidney Marker Assay - Product Status 77
Table 126: RapiPlex Platform - Kidney Marker Assay - Product Description 77
Table 127: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 78
Table 128: Micropoc-CAT - Haemotology Assay - Product Status 78
Table 129: Micropoc-CAT - Haemotology Assay - Product Description 78
Table 130: Micropoc-CAT - Inflammation Assay - Product Status 79
Table 131: Micropoc-CAT - Inflammation Assay - Product Description 79
Table 132: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 80
Table 133: Heart Failure Genomics Risk Test - Product Status 80
Table 134: Heart Failure Genomics Risk Test - Product Description 80
Table 135: Plasminogen Activator Inhibitor Type-1 Test - Product Status 81
Table 136: Plasminogen Activator Inhibitor Type-1 Test - Product Description 81
Table 137: Troponin-I Test - Product Status 81
Table 138: Troponin-I Test - Product Description 82
Table 139: Cellex Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
Table 140: Point-Of-Care Test - Bacterial Vaginosis - Product Status 83
Table 141: Point-Of-Care Test - Bacterial Vaginosis - Product Description 83
Table 142: Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Pipeline Products & Ongoing Clinical Trials Overview 84
Table 143: Antibody Based Diagnostic Assay - Anticoagulants - Product Status 84
Table 144: Antibody Based Diagnostic Assay - Anticoagulants - Product Description 84
Table 145: Claremont BioSolutions Pipeline Products & Ongoing Clinical Trials Overview 85
Table 146: Integrated Disposable Assay - Clostridium Difficile - Product Status 85
Table 147: Integrated Disposable Assay - Clostridium Difficile - Product Description 85
Table 148: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 86
Table 149: Diagnostic Test - Periodontal Disease - Product Status 86
Table 150: Diagnostic Test - Periodontal Disease - Product Description 86
Table 151: Tumor Resistance Rapid Assay - Product Status 87
Table 152: Tumor Resistance Rapid Assay - Product Description 87
Table 153: CTK Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
Table 154: Diagnostic Assay - Chikungunya - Product Status 88
Table 155: Diagnostic Assay - Chikungunya - Product Description 88
Table 156: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 89
Table 157: ISH/IHC Assay - Colorectal Cancer - Product Status 89
Table 158: ISH/IHC Assay - Colorectal Cancer - Product Description 89
Table 159: ISH/IHC Assay - Lung Cancer - Product Status 90
Table 160: ISH/IHC Assay - Lung Cancer - Product Description 90
Table 161: ISH/IHC Assay - Pancreatic Cancer - Product Status 90

Figure 1: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Stage of Development 22
Figure 2: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Territory 23
Figure 3: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Regulatory Path 24
Figure 4: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
Figure 5: Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Ongoing Clinical Trials 26

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +